MAPK3 and neuroblastoma: The pre-treatment of neuroblastoma cells with BJ reduced the ERK1/2 and p38 phosphorylation, indicating that the neuroprotective effects of BJ against 6-OHDA toxicity is related to the modulation of MAPKs pathways.